Reply

American Journal of Obstetrics and Gynecology

Volumn 210, Issue 4, 2014, Pages 380-381

  Timor Tritsch, Ilan E ^a   Monteagudo, Ana ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; METHOTREXATE;

CESAREAN SCAR PREGNANCY; CESAREAN SECTION; FEMALE; FOLLOW UP; HUMAN; LETTER; PLACENTA ACCRETA; PRIORITY JOURNAL; SCAR; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

CESAREAN SECTION; FEMALE; HUMANS; PLACENTA ACCRETA; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY, ECTOPIC;

EID: 84897128258     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.01.028     Document Type: Letter

References (3)

1. S. Bodur, I. Gun, and R. Guido What is the role of primary methotrexate treatment in scar ectopic pregnancy? Am J Obstet Gynecol 210 2014 379 380
2. I.E. Timor-Tritsch, and A. Monteagudo Unforeseen consequences of the increasing rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy: a review Am J Obstet Gynecol 207 2012 14 29
3. Timor-Tritsch Correction Am J Obstet Gynecol 210 2014 371 374